Biopharmaceutical Transfusion, Clinical Trials & Clinical Blood Banking (P01440)

? Credit Points : 20 ? SCQF Level : 11 ? Acronym : MED-P-P01440

To provide an understanding of scientific basis, and application , of large scale pharmaceutical preparation of prescription medicines (plasma products ) from blood plasma as well as the approach to regulation and licensing of these products.

To provide an understanding of scientific basis of adverse immunological reactions to transfusion and the interpretation of these reactions in clinical practice.

Entry Requirements

? This course is not available to visting students.

? Pre-requisites : Honours degree in relevant biological science and two years experience in a relevant health provision environment

Subject Areas

Home subject area

General Courses (Medicine), (Medicine, Schedule R)

Delivery Information

? Normal year taken : Postgraduate

? Delivery Period : Semester 1 (Blocks 1-2)

? Contact Teaching Time : 35 hour(s) per week for 1 weeks

? Additional Class Information : The course will be delivered as a series of lectures combined with tutorials, spot tests and assessment exercise as a one-week residential course in Edinburgh. Students will be assigned background-learning work prior to this week.

Summary of Intended Learning Outcomes

At the completion of this course the student should understand the principles and practice of:
-Plasma Fractionation
-The range of plasma products and their clinical uses
-Clinical trials and regulation of plasma products

At the completion of the course the student should also be aware of the scientific basis and application in clinical practice of:

-haemolytic disease of the newborn.
-ante-natal serological techniques
-the investigation of transfusion reactions
-the laboratory investigation of immune haemolysis
-the adverse immunological effects of transfusion

Assessment Information

Written assignment: 4,000-5,000 words (60%)
Participation in assessments during the week's course (spot tests, or multi-choice question (MCQ) assessment: 40%)